Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Written Informed Consent;~* Bipolar disorder with most recent episode depressed;~* Outpatient status~Exclusion Criteria:~* Patients with a current Axis I disorder other than bipolar disorder within 6 months of screening;~* Patients whose current episode of depression exceeds 12 months or is less than 4 weeks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).